We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Revokes Orphan Drug Designation for Opioid Addiction Treatment
FDA Revokes Orphan Drug Designation for Opioid Addiction Treatment
The FDA has revoked Indivior’s orphan drug designation for its opioid addiction treatment Sublocade (buprenorphine extended-release injection) finding that it was improperly granted.